Global Pharmaceuticals & Biotech Most Popular Stocks

Seegene

Market Cap: ₩1.2t

Manufactures and sells molecular diagnostics products worldwide.

Hangzhou Biotest BiotechLtd

Market Cap: CN¥5.8b

Engages in the research and development, manufacture, sale, and service of in vitro diagnostic assays and reagents, and instruments in China and internationally.

Tianjin Lisheng PharmaceuticalLtd

Market Cap: CN¥5.8b

Engages in the research and development, production, and sale of pharmaceutical products in China.

Phathom Pharmaceuticals

Market Cap: US$812.1m

A biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases.

Shanghai Haixin Group

Market Cap: CN¥5.8b

Engages in the pharmaceutical, textile and clothing, and finance businesses.

Zhejiang Int'l GroupLtd

Market Cap: CN¥5.8b

Engages in the wholesale and retail of pharmaceuticals and medical devices.

Geron

Market Cap: US$810.3m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

GI Innovation

Market Cap: ₩1.1t

A bio-venture company, engages in the research and development of protein new drugs.

Laekna

Market Cap: HK$6.2b

An investing holding company, engages in the discovering, development, and commercialization of therapies for patients with cancer, metabolic diseases, and liver fibrosis in the People’s Republic of China, the United States of America, and South Korea.

UroGen Pharma

Market Cap: US$798.5m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

G2GBIO

Market Cap: ₩1.1t

A clinical-stage biotech company, provides pharmaceutical products.

Rezolute

Market Cap: US$796.4m

A late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.

ChemPartner PharmaTechLtd

Market Cap: CN¥5.7b

Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide.

CareDx

Market Cap: US$791.5m

Engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.

China Shineway Pharmaceutical Group

Market Cap: HK$6.2b

An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.

Jenkem Technology

Market Cap: CN¥5.6b

Develops and manufactures polyethylene glycol derivative (PEG) products in China.

Hubei Hongyuan Pharmaceutical Technology

Market Cap: CN¥5.6b

Engages in the production and sale of pharmaceutical products in China and internationally.

Tong Ren Tang Technologies

Market Cap: HK$6.1b

Produces and distributes Chinese medicine products in Mainland China and Hong Kong.

Fortrea Holdings

Market Cap: US$788.1m

A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

Chimin Health Management

Market Cap: CN¥5.6b

Researches, develops, produces, and sells human medicines and medical devices in China and internationally.

Zenas BioPharma

Market Cap: US$784.1m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies.

Suzhou Highfine Biotech

Market Cap: CN¥5.6b

Manufactures and sells chemicals for pharmaceutical research and development, and API production companies in China.

Mochida Pharmaceutical

Market Cap: JP¥117.0b

Manufactures and sells pharmaceuticals and healthcare products in Japan.

MBX Biosciences

Market Cap: US$774.7m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders.

ProKidney

Market Cap: US$771.0m

A clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.

Akums Drugs and Pharmaceuticals

Market Cap: ₹68.4b

Manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally.

Pell Bio-Med Technology

Market Cap: NT$23.4b

A biomedical company, engages in the development of cell culture technologies and techniques for therapeutic applications.

Shanghai MicuRx Pharmaceutical

Market Cap: CN¥5.5b

A biopharmaceutical company, discovers, develops, and commercialize drugs for unmet medical needs.

Beijing Science Sun Pharmaceutical

Market Cap: CN¥5.4b

A biopharmaceutical company, engages in the research and development, production, and sales of injections in China.

TYK Medicines

Market Cap: HK$5.9b

A clinical-stage biopharmaceutical company, research, development and commercialization of pharmaceutical products.

Takara Bio

Market Cap: JP¥113.4b

Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.

Relay Therapeutics

Market Cap: US$755.2m

Operates as a clinical-stage precision medicines company.

Frontier Biotechnologies

Market Cap: CN¥5.4b

A commercial-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes various medicines that improve patient health in China.

Niagen Bioscience

Market Cap: US$752.0m

Operates as a bioscience company engages in developing healthy aging products.

Shanghai Xiao Fang PharmaceuticalLtd

Market Cap: CN¥5.4b

Shanghai Xiao Fang Pharmaceutical Co., Ltd produces and sells medicines in China.

Curiox Biosystems

Market Cap: ₩1.1t

Manufactures and sells medical appliances and instruments in South Korea.